Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

Early-onset menopause linked to increased symptoms of anxiety and depression (opens in a new tab)

medicalxpress.com · 2026-10-06

Short answerEvidenceSource

Short answer

Mostly supported

Mostly supported.

One claim goes further than the study.

  • 5 supported
  • 1 overstated

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mostly supported

One claim overstates the study. Five of six check out.

  • 5 supported
  • 1 overstated
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

6 claims in this story

Showing all 6 claimsChoose a verdict to focus the list.

Claim 1 of 6OverstatedWomen who had already entered the menopausal transition were 44% more likely to experience clinically significant anxiety symptoms than women who had not yet entered the menopausal transition, after accounting for smoking, alcohol consumption, body mass index and education.View evidenceHide evidence

As stated44% more likely

Why this verdict

The adjusted association is supported in direction and covariate set: adjusted OR 1.44 after adjustment for smoking, alcohol, BMI, and education. However, the story's '44% more likely to experience' wording translates an odds ratio into a probability/risk statement; the paper evidence is an adjusted odds ratio, not a directly estimated 44% higher risk.

1

Study evidence

Climacteric women had higher prevalence of significant anxiety symptoms on the HSCL-25 at age 46 compared with preclimacteric women (22.6% vs 16.0%).Unadjusted OR 1.53 (95% CI 1.16–2.02); adjusted OR 1.44 (95% CI 1.04–2.00) after controlling for smoking, alcohol, BMI, and education.

“This prospective cohort study included 2632 female participants from the Northern Finland Birth Cohort 1966 who participated in the 46-year follow-up.”
Claim 2 of 6SupportedA study by the University of Oulu found that women who entered menopause earlier than usual reported more symptoms of anxiety and depression than women of the same age who had not yet entered menopause.View evidenceHide evidence

Why this verdict

The abstract profile supports an association at age 46 between advanced climacteric/menopausal status and higher prevalence of clinically relevant anxiety and depressive symptoms versus preclimacteric women of the same cohort age. The wording 'entered menopause' is a simplified rendering of 'climacteric/advanced menopausal status,' but the story frames the finding as symptom reporting rather than causation.

1

Study evidence

Climacteric women had higher prevalence of significant anxiety symptoms on the HSCL-25 at age 46 compared with preclimacteric women (22.6% vs 16.0%).Unadjusted OR 1.53 (95% CI 1.16–2.02); adjusted OR 1.44 (95% CI 1.04–2.00) after controlling for smoking, alcohol, BMI, and education.

“This prospective cohort study included 2632 female participants from the Northern Finland Birth Cohort 1966 who participated in the 46-year follow-up.”
Claim 3 of 6SupportedThe study examined data from more than 2,600 women from the Northern Finland Birth Cohort 1966, who were 46 years old at the time of the study.View evidenceHide evidence

As statedmore than 2,600 women; age 46

Why this verdict

The paper profile states that the prospective cohort study included 2,632 female participants from the Northern Finland Birth Cohort 1966 who participated in the 46-year follow-up.

1

Study evidence

Climacteric women had higher prevalence of significant anxiety symptoms on the HSCL-25 at age 46 compared with preclimacteric women (22.6% vs 16.0%).Unadjusted OR 1.53 (95% CI 1.16–2.02); adjusted OR 1.44 (95% CI 1.04–2.00) after controlling for smoking, alcohol, BMI, and education.

“This prospective cohort study included 2632 female participants from the Northern Finland Birth Cohort 1966 who participated in the 46-year follow-up.”
2

Study evidence

Antidepressant purchase rates were higher among climacteric women in crude registry-based comparisons (48% vs 41%, p = 0.012).48% vs 41%, p = 0.012

“Information on psychiatric medication purchases was retrieved from a national registry.”
Claim 4 of 6SupportedClinically significant anxiety symptoms were reported by approximately 23% of women who had entered the menopausal transition, compared with 16% of women in the comparison group.View evidenceHide evidence

As stated23% vs 16%

Why this verdict

The profile reports HSCL-25 clinically relevant anxiety symptoms in 22.6% of climacteric women versus 16.0% of preclimacteric women, matching the story's approximate 23% versus 16% comparison.

1

Study evidence

Climacteric women had higher prevalence of significant anxiety symptoms on the HSCL-25 at age 46 compared with preclimacteric women (22.6% vs 16.0%).Unadjusted OR 1.53 (95% CI 1.16–2.02); adjusted OR 1.44 (95% CI 1.04–2.00) after controlling for smoking, alcohol, BMI, and education.

“This prospective cohort study included 2632 female participants from the Northern Finland Birth Cohort 1966 who participated in the 46-year follow-up.”
Claim 5 of 6SupportedClinically significant depressive symptoms were also more common among women who had entered the menopausal transition, with just over 30% reporting symptoms compared with just under 25% in the comparison group.View evidenceHide evidence

As statedjust over 30% vs just under 25%

Why this verdict

The abstract profile reports depressive symptoms on a questionnaire-specified measure in 30.1% of climacteric women versus 24.6% of preclimacteric women, consistent with 'just over 30%' versus 'just under 25%.' The broader depression evidence is instrument-dependent, but this specific prevalence comparison is supported.

1

Study evidence

Climacteric women had higher prevalence of significant anxiety symptoms on the HSCL-25 at age 46 compared with preclimacteric women (22.6% vs 16.0%).Unadjusted OR 1.53 (95% CI 1.16–2.02); adjusted OR 1.44 (95% CI 1.04–2.00) after controlling for smoking, alcohol, BMI, and education.

“This prospective cohort study included 2632 female participants from the Northern Finland Birth Cohort 1966 who participated in the 46-year follow-up.”
Claim 6 of 6SupportedThe researchers said the findings highlight the importance of paying attention to mental health during menopause, particularly when menopause begins at a younger-than-usual age.View evidenceHide evidence

Why this verdict

The profile states that the authors concluded mental health support is important during and after menopause, particularly for those with early-onset menopause, which aligns with the story's interpretation that the findings highlight attention to mental health during earlier-than-usual menopause.

1

Study evidence

Climacteric women had higher prevalence of significant anxiety symptoms on the HSCL-25 at age 46 compared with preclimacteric women (22.6% vs 16.0%).Unadjusted OR 1.53 (95% CI 1.16–2.02); adjusted OR 1.44 (95% CI 1.04–2.00) after controlling for smoking, alcohol, BMI, and education.

“This prospective cohort study included 2632 female participants from the Northern Finland Birth Cohort 1966 who participated in the 46-year follow-up.”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • Instrument-dependent depression results: the BDI-21 depressive-symptom association was higher in crude prevalence but did not remain independently associated after adjustment.

    The story presents depressive symptoms generally as more common but does not mention that one depression instrument's association did not persist after covariate adjustment, a limitation that changes the strength and generality of the depression finding.

    From prospective cohort study

  • Observational and largely cross-sectional symptom analysis: exposure classification and self-reported symptom outcomes were assessed at the same 46-year follow-up, limiting causal inference.

    The story uses associational language, but its caveats do not explicitly state the observational/cross-sectional nature of the symptom comparison or the resulting limitation on causal interpretation.

    From prospective cohort study

  • Residual confounding remains possible despite adjustment for smoking, alcohol consumption, BMI, and education.

    The story mentions the adjusted covariates but does not mention that adjustment does not eliminate possible unmeasured or residual confounding.

    From prospective cohort study

  • Secondary registry medication-purchase analysis: crude antidepressant and benzodiazepine purchase rates were higher among climacteric women, but adjusted models found no independent association.

    The paper profile identifies this as a secondary contribution, but the story does not cover the medication-purchase findings or the fact that adjusted registry associations were null.

    From cohort with registry linkage

5 things the story did carry across
  • Primary study design and population: observational cohort analysis of NFBC1966 women at the 46-year follow-up, with 2,632 participants and 356 classified as climacteric.
  • Main anxiety finding: climacteric status at age 46 was associated with higher prevalence of clinically relevant anxiety symptoms, including an adjusted OR of 1.44.
  • Main depressive-symptom finding: one questionnaire metric showed higher depressive-symptom prevalence in climacteric women, 30.1% versus 24.6%, with adjusted OR 1.39.
  • Outcomes were self-reported symptom scales rather than clinical diagnoses of anxiety or depression.
  • Author interpretation: mental health support is important during and after menopause, particularly with early-onset menopause.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

2

Evidence read

study summary

Lead result

human in vivo

1Lead resulthuman in vivoAssess whether advanced menopausal (climacteric) status at age 46 is associated with clinically relevant anxiety and depressive symptoms at age 46 in women from the Northern Finland Birth Cohort 1966.prospective cohort studyExpand

In plain English

In the Northern Finland Birth Cohort 1966 46-year follow-up (n=2632; 356 [13%] classified as climacteric), climacteric (advanced menopausal) status at age 46 was associated with higher prevalence of clinically relevant anxiety symptoms and with higher prevalence of depressive symptoms on at least one questionnaire metric; associations for anxiety and for one depression measure persisted after adjustment for smoking, alcohol, BMI, and education, while the Beck Depression Inventory association did not remain significant after adjustment. Medication-purchase registry comparisons showed higher crude rates of antidepressant and benzodiazepine purchases among climacteric women (ages 40–57) but these differences were not independently associated after multivariable adjustment.

Key findings

  • Climacteric women had higher prevalence of significant anxiety symptoms on the HSCL-25 at age 46 compared with preclimacteric women (22.6% vs 16.0%).Unadjusted OR 1.53 (95% CI 1.16–2.02); adjusted OR 1.44 (95% CI 1.04–2.00) after controlling for smoking, alcohol, BMI, and education.
  • Climacteric women more frequently reported depressive symptoms on a questionnaire metric reported in the abstract (30.1% vs 24.6%).Adjusted OR 1.39 (95% CI 1.03–1.85) after controlling for smoking, alcohol, BMI, and education.
“This prospective cohort study included 2632 female participants from the Northern Finland Birth Cohort 1966 who participated in the 46-year follow-up.”
What this piece can’t prove
  • Observational cohort analysis with exposure and self-reported symptom outcomes assessed at the same 46-year follow-up visit (limits causal inference).
  • Outcomes are self-reported symptom scales (HSCL-25 and BDI-21); measurement differences between instruments produced inconsistent adjusted results.
  • Relatively small proportion classified as climacteric (356/2632, 13%), which affects subgroup sample size and precision.
  • Multivariable adjustment included smoking, alcohol, BMI, and education, but residual confounding from unmeasured factors cannot be excluded.
2secondary dataAssess whether climacteric status at age 46 is associated with subsequent psychiatric medication purchases (antidepressants, benzodiazepine derivatives) during midlife (ages ~40–57) using national registry data.cohort with registry linkageExpand

In plain English

In a prospective cohort (Northern Finland Birth Cohort 1966) linkage to a national pharmacy registry, climacteric (advanced menopausal) status at age 46 was associated with higher crude proportions of antidepressant and benzodiazepine-derivative purchases across ages 40–57, but these associations did not remain statistically significant in multivariable-adjusted logistic regression models.

Key findings

  • Antidepressant purchase rates were higher among climacteric women in crude registry-based comparisons (48% vs 41%, p = 0.012).48% vs 41%, p = 0.012
  • Benzodiazepine-derivative purchase rates were higher among climacteric women in crude registry-based comparisons (18.3% vs 13.3%, p = 0.012).18.3% vs 13.3%, p = 0.012
“Information on psychiatric medication purchases was retrieved from a national registry.”
What this piece can’t prove
  • Outcome window (ages 40–57) includes periods both before and after exposure ascertainment at age 46, complicating temporality and causal interpretation.
  • Abstract does not report which covariates were included in the multivariable model for medication outcomes, nor the adjusted effect estimates or confidence intervals.
  • Registry-based purchase records measure dispensing events and may not precisely reflect clinical diagnoses, symptom severity, adherence, or indication.

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 15 candidate papers

Selected

Menopausal status at the age of 46: Its association with depressive and anxiety symptoms and morbidity in women-A northern Finland birth cohort 1966 study.

Acta Obstetricia Et Gynecologica Scandinavica · 2026 · PubMed, Europe PMC, Crossref

Tessa (opens in a new tab)Source (opens in a new tab)
Candidate

Cloninger’s temperament dimensions and longitudinal alcohol use in early mid-life: a Northern Finland birth cohort 1966 study

2018 · Crossref

Source (opens in a new tab)

And 9 more candidates considered.